A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33241520.
- Also identified by DOI 10.1007/s00330-020-07527-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis.• Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working.• Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.
Medical subject headings
- Prostatic Neoplasms